Stay updated on PM01183 Escalating Doses with Doxorubicin Clinical Trial

Sign up to get notified when there's something new on the PM01183 Escalating Doses with Doxorubicin Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PM01183 Escalating Doses with Doxorubicin Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    0.7%
    Check dated 2026-10-25T02:32:47.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The site footer revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T02:17:44.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The site revision label in the footer changed from v3.7.0 to v3.7.1. The study record history remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-11T02:50:20.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    A new revision v3.7.0 has been added to the Study Record History and the previous revision v3.6.6 has been removed, reflecting an update to the page version in ClinicalTrials.gov. This is an administrative change indicating the page was updated.
    Difference
    0.1%
    Check dated 2026-09-20T01:31:48.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.6) was added to the Record History, replacing the previous v3.6.5 and reflecting a site update.
    Difference
    0.1%
    Check dated 2026-08-29T21:57:30.000Z thumbnail image
  6. Check
    81 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5 in the study record history.
    Difference
    0.1%
    Check dated 2026-08-08T20:02:06.000Z thumbnail image

Stay in the know with updates to PM01183 Escalating Doses with Doxorubicin Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PM01183 Escalating Doses with Doxorubicin Clinical Trial page.